The HFD+STZ group had significantly higher serum AST, ALT, AST/ALT ratio, CHE, TC, TG, GLU, and LDL levels as well as reduced HDL levels than the control (p < 0.05 or p < 0.01), reflecting a global metabolic disorder and an impairment in liver function. The gene discussed is GPT; the disease is Other metabolic disease.